MGI at the 14th AORTIC International Cancer Conference in Senegal

Dakar, Senegal

Share

MGI at the 14th AORTIC International Cancer Conference in Senegal
MGI at the 14th AORTIC International Cancer Conference in Senegal

From November 2nd to 6th, 2023, Dakar, Senegal played host to the 14th AORTIC International Conference on Cancer, and MGI was proud to be an exhibitor at this significant event.

Bringing together multidisciplinary specialists from the African and global cancer community, the conference aimed to support evidence-based interventions and innovative programs focused on the prevention and control of cancer in Africa.

Our local team was on hand to connect with attendees, sharing insights into MGI's mission to lead life science innovation. We engaged in discussions on how our cutting-edge technologies can elevate NGS research and diagnostic capabilities, pushing the boundaries of possibilities in the field.

For those who may have missed the event, detailed information about the conference and its program can be found here

We extend our sincere thanks to everyone who visited our booth, contributing to insightful discussions and fostering collaboration. We look forward to future opportunities and collaborations that will continue our journey in the pursuit of innovation and progress in the field of life sciences.

From November 2nd to 6th, 2023, Dakar, Senegal played host to the 14th AORTIC International Conference on Cancer, and MGI was proud to be an exhibitor at this significant event.

Bringing together multidisciplinary specialists from the African and global cancer community, the conference aimed to support evidence-based interventions and innovative programs focused on the prevention and control of cancer in Africa.

Our local team was on hand to connect with attendees, sharing insights into MGI's mission to lead life science innovation. We engaged in discussions on how our cutting-edge technologies can elevate NGS research and diagnostic capabilities, pushing the boundaries of possibilities in the field.

For those who may have missed the event, detailed information about the conference and its program can be found here

We extend our sincere thanks to everyone who visited our booth, contributing to insightful discussions and fostering collaboration. We look forward to future opportunities and collaborations that will continue our journey in the pursuit of innovation and progress in the field of life sciences.

From November 2nd to 6th, 2023, Dakar, Senegal played host to the 14th AORTIC International Conference on Cancer, and MGI was proud to be an exhibitor at this significant event.

Bringing together multidisciplinary specialists from the African and global cancer community, the conference aimed to support evidence-based interventions and innovative programs focused on the prevention and control of cancer in Africa.

Our local team was on hand to connect with attendees, sharing insights into MGI's mission to lead life science innovation. We engaged in discussions on how our cutting-edge technologies can elevate NGS research and diagnostic capabilities, pushing the boundaries of possibilities in the field.

For those who may have missed the event, detailed information about the conference and its program can be found here

We extend our sincere thanks to everyone who visited our booth, contributing to insightful discussions and fostering collaboration. We look forward to future opportunities and collaborations that will continue our journey in the pursuit of innovation and progress in the field of life sciences.

From November 2nd to 6th, 2023, Dakar, Senegal played host to the 14th AORTIC International Conference on Cancer, and MGI was proud to be an exhibitor at this significant event.

Bringing together multidisciplinary specialists from the African and global cancer community, the conference aimed to support evidence-based interventions and innovative programs focused on the prevention and control of cancer in Africa.

Our local team was on hand to connect with attendees, sharing insights into MGI's mission to lead life science innovation. We engaged in discussions on how our cutting-edge technologies can elevate NGS research and diagnostic capabilities, pushing the boundaries of possibilities in the field.

For those who may have missed the event, detailed information about the conference and its program can be found here

We extend our sincere thanks to everyone who visited our booth, contributing to insightful discussions and fostering collaboration. We look forward to future opportunities and collaborations that will continue our journey in the pursuit of innovation and progress in the field of life sciences.

About MGI

MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.

MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.

The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.

For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.

About MGI

MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.

MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.

The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.

For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.

About MGI

MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.

MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.

The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.

For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.

About MGI

MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.

MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.

The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.

For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.

GENOMICS

CANCER DIAGNOSTICS

SEQUENCING

NGS

AORTIC 2023

Share this article :

Share

More Events

Join MGI at Spatial Biology UK 2024
Join MGI at Spatial Biology UK 2024
Join MGI at Spatial Biology UK 2024
Join MGI at Spatial Biology UK 2024

Mar 18, 2024

Join MGI at Spatial Biology UK 2024

Discover Genomic Innovations with MGI at Spatial Biology UK 2024! Join us on March 18th-19th at booth 15 at Novotel London West. Don't miss out!

Join us at EACR-AACR-IACR Basic and Translational Research Conference
Join us at EACR-AACR-IACR Basic and Translational Research Conference
Join us at EACR-AACR-IACR Basic and Translational Research Conference
Join us at EACR-AACR-IACR Basic and Translational Research Conference

Jan 27, 2024

Join us at EACR-AACR-IACR Basic and Translational Research Conference

Join us at booth 5 during the EACR-AACR-IACR Basic and Translational Research Conference with the MGI Team in Dublin, Ireland from February 27-29.

Join us at The Festival of Genomics & Biodata in January
Join us at The Festival of Genomics & Biodata in January
Join us at The Festival of Genomics & Biodata in January
Join us at The Festival of Genomics & Biodata in January

Jan 24, 2024

Join us at The Festival of Genomics & Biodata in January

Join us at booth 98 with MGI Tech during The Festival of Genomics & Biodata on January 24th-25th, 2024, at ExCeL in London.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.